Posizioni attive di Elisa Scarselli
Società | Posizione | Inizio | Fine |
---|---|---|---|
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Direttore Tecnico/Scientifico/R&S | 01/01/2007 | - |
Fondatore | 01/01/2007 | - | |
Nouscom Srl | Direttore Tecnico/Scientifico/R&S | 01/01/2015 | - |
Fondatore | 01/01/2015 | - |
Storia della carriera di Elisa Scarselli
Statistiche
Distribuzione geografica
Svizzera | 2 |
Italia | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Settori
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
Nouscom Srl | Commercial Services |
- Borsa valori
- Insiders
- Elisa Scarselli
- Esperienza